Session 12 - Neurooncology
Glioblastoma, IDH-wildtype

Programme

• 15:45 – 16:15 25 Min. 5 Min.

  • Invited Talk
  • S12-NO-T1

  Therapeutic resistance in gliomas

  • Keith L. Ligon (Boston, MA, US)
• 16:15 – 16:25 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A7

  Patterns and evolution of structural complexity in 323 GBM whole genomes

  • Alhafidz Hamdan (Edinburgh, GB)
• 16:25 – 16:35 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A8

  Clinical and molecular characterization of extracranial metastases from glioblastomas

  • Julie Jacobsen (Copenhagen, DK)
• 16:35 – 16:45 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A9

  A rationale to screen Mismatch repair deficiency among adult patients with glioma – an analysis of 1225 cases

  • Franck Bielle (Paris, FR)
• 16:45 – 16:55 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A10

  The clinicopathological, molecular characteristics and prognosis of adult epithelioid glioblastomas – a report of 39 cases

  • Shaoyan Xi (Guangzhou, CN)
• 16:55 – 17:05 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A11

  Concurrent RB1 and P53 pathway alterations predispose to the development of primitive neuronal component in glioblastoma through the upregulation of EBF3

  • Pietro Luigi Poliani (Milan, IT)
• 17:05 – 17:15 7 Min. 3 Min.

  • Abstract Talk
  • S12-NO-A12

  DNA hypomethylator phenotype remodels oncogenic glutamate metabolism in glioblastoma

  • Kenta Masui (Tokyo, JP)